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Abstract In the central nervous system, oligodendrocytes
synthesize a specialized membrane, the myelin membrane,
which enwraps the axons in a multilamellar fashion to
provide fast action potential conduction and to ensure
axonal integrity. When compared to other membranes, the
composition of myelin membranes is unique with its rela-
tively high lipid to protein ratio. Their biogenesis is quite
complex and requires a tight regulation of sequential
events, which are deregulated in demyelinating diseases
such as multiple sclerosis. To devise strategies for reme-
dying such defects, it is crucial to understand molecular
mechanisms that underlie myelin assembly and dynamics,
including the ability of specific lipids to organize proteins
and/or mediate protein–protein interactions in healthy
versus diseased myelin membranes. The tight regulation of
myelin membrane formation has been widely investigated
with classical biochemical and cell biological techniques,
both in vitro and in vivo. However, our knowledge about
myelin membrane dynamics, such as membrane fluidity in
conjunction with the movement/diffusion of proteins and
lipids in the membrane and the specificity and role of
distinct lipid–protein and protein–protein interactions, is
limited. Here, we provide an overview of recent findings
about the myelin structure in terms of myelin lipids, pro-
teins and membrane microdomains. To give insight into
myelin membrane dynamics, we will particularly highlight
the application of model membranes and advanced bio-
physical techniques, i.e., approaches which clearly provide
an added value to insight obtained by classical biochemical
techniques.
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Introduction
In the central nervous system (CNS), processes protrude
from oligodendrocytes (OLGs) at the end of which sheet-
like extensions are formed, the myelin membranes, which
ensheath axons in a multilamellar fashion to provide proper
saltatory nerve conduction [1]. Myelin membranes are
unique in that approx. 70 % of their dry weight consists of
lipids, in particular cholesterol and the galactolipids
galactosylceramide (GalC) and sulfatide (Table 1, [1, 2]).
Myelin also contains a specific repertoire of myelin pro-
teins, among which proteolipid protein (PLP) and myelin
basic protein (MBP) are the most abundant ones [1–3]. The
interactions between lipids and proteins are pivotal for
myelin formation and maintenance, regulating protein
transport to and the molecular organization within the
myelin sheath [2, 4, 5]. Thus, biochemical and biophysical
properties of the lipids actively control (myelin) protein
sorting, while (myelin) proteins, in turn, are able to orga-
nize lipids, thereby creating regions of specialized
molecular packing (e.g. lipid rafts) and dynamics, relevant
to their functioning [6–8]. These membrane subdomains
are usually enriched in cholesterol, glycosphingolipids and
phospholipids with saturated fatty acids, providing a more
ordered i.e., less dynamic microdomain organization
(‘liquid ordered’) compared to the remainder of the mem-
brane, which is more fluid or ‘liquid disordered’. Indeed,
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the ‘lipid raft’ concept is also very important for myelin
research given that such rafts play a role in orchestrating
signaling platforms that regulate OLG behavior, and sort-
ing of several myelin proteins [2, 4, 6, 9, 10].
Since all elements of the myelination machinery require
a careful mutual orchestration, a defect in one of them
could affect the entire machinery. Thus, alterations in
protein–lipid trafficking or misfolding in conformational
changes of myelin proteins may cause severe overall patho-
neurological consequences. Therefore, insight into the
spatio-temporal architecture of OLGs and their myelin
membranes, the important players in myelin membranes is
crucial to improve our understanding of the (re)myelination
machinery, and hence the potential in developing (novel)
therapeutic strategies. So far, the majority of studies in
myelin membrane research have been performed with liv-
ing cells. However, model membranes such as large
unilamellar (LUVs) or giant unilamellar vesicles (GUVs)
in conjunction with classical biophysical techniques are
quite promising tools to investigate the lipid organization
and domain assembly, as well as lipid–lipid and lipid–
protein interactions [3, 11–15]. Additionally, single-mole-
cule biophysical optical microscopy offers a set of highly
sophisticated tools for gaining detailed molecular insight
into the dynamic organization of lipids and proteins, which,
most importantly, can be accomplished in a non-invasive
manner, also in living cells. These approaches include
photon counting histogram (PCH) analyses [16], F tech-
niques [e.g., fluorescence recovery after photobleaching
(FRAP) [17] and fluorescence correlation spectroscopy
(FCS) [18], advanced FCS techniques (e.g. scanning [19],
dual focus [20], z-scan [21], spot variation FCS [22]),
fluorescence cross-correlation spectroscopy (FCCS) [23],
and Fo¨rster resonance energy transfer (FRET) [24, 25]),
image correlation techniques (e.g., raster image correlation
spectroscopy (RICS) [26, 27], and number and brightness
analyses (N&B) [28]). Here, we will summarize and dis-
cuss myelin assembly and maintenance in terms of the
interaction of its structural elements, i.e., lipids, known to
be enriched in the myelin membrane, and myelin-specific
proteins. Additionally, we will highlight the versatility of
biophysical technology in OLG-myelin research, and the
impact of such approaches in improving our understanding
of how lipids and proteins regulate the tight spatio-tem-
poral organization of the myelin membrane and, thereby,
its physiological function. Notably, a combined approach
of highly advanced biophysical and classical biochemical
techniques may not only clarify basic questions in myelin
biology, a similar approach may also be most beneficial
towards advancing our understanding of numerous other
cell biologically relevant processes, ranging from vesicu-
lation to membrane fusion and cellular secretion.
Myelin biogenesis and structure: involvement
of a set of specialized proteins and lipids
The multilayered myelin membrane displays a distinct and
complex architecture, i.e., in the process of enwrapping
axons, the outer leaflets of the myelin membranes appose
each other, thereby creating the intraperiod line, while the
condensed cytoplasmic surface constitutes the major dense
Table 1 Major myelin lipids
Lipid % total dry weight of myelin Comments Reference Notes
Human Bovine Rat
Cholesterol 27.7 28.1 27.3 Rate limiting for CNS myelination





22.7 24 23.3 Role in OLG maturation
Role in proper CNS node and paranode formationa
Role in electrophysioloigcal properties of myelina
Stabilization and maintenance of axoglial adhesion
at the paranodea
Maintenance of compact myelina
Role in myelin integrity and stabilitya
[60, 65, 175–179] Mainly C(24:1)
Sulfatide 3.8 3.6 7.1 Negative regulator of OLG differentiation
Role in sodium channels clustering
Role in paranode formation
Role in NF155 organization
[63, 67, 180, 181] Mainly C(24:1)
a The mentioned comment are obtained from CGT knock-out mouse studies, therefore these findings are also relevant for the function of
sulfatide
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line ([1, 5], Fig. 1a, b), as readily visualized by electron
microscopy (EM). The myelinated segments of the axons,
the so-called internodes, are interchanged with myelin-de-
void areas, named the ‘nodes of Ranvier’, where sodium
channels are localized that generate a membrane potential
that drives the action potential along the axon in a saltatory
manner. Besides axonal enwrapping, myelin compaction
takes place, which thus gives rise to areas of compact and
non-compact myelin [1, 5]. Recent findings in rodents
suggest that the compaction of the myelin sheath starts
from the outer tongue and gradually shifts towards the inner
tongue (leading edge of the sheath, Fig. 1a, [29]). Within
the internodes different degrees of compaction can be dis-
cerned. Although mainly compact within the inter-node,
regions at their edges, known as ‘paranodes’, consist of
non-compact myelin (Fig. 1a). Interestingly, the molecular
composition of compact and non-compact myelin differs;
i.e., the major myelin proteins PLP and MBP together with
the glycosphingolipid GalC reside in compact myelin,
whereas other myelin proteins, such as 155-kDa neuro-
fascin (NF155), together with the glycosphingolipid
sulfatide localize in the paranodal region of non-compact
myelin [2, 30]. The proper ‘compartmentalization’ of the
myelin sheath accomplished in this manner is crucial for its
function, because any alterations in the complex interre-
lated lipid and protein organization of myelin structure
might cause more or less severe demyelinating, dysmyeli-
nating, and hypomyelinating diseases. For example, in the
hypomyelinating diseases Pelizaeus-Merzbacher disease
(PMD) and the less severe spastic paraplegia 2 (SPG2)
mutations, deletions or duplication of the PLP gene lead to
abnormal myelin formation [31–34]. The mutations and
deletions induce an alteration in the protein conformation,
thereby perturbing PLP transport to the myelin sheath and
affecting intracellular cholesterol/lipid transport to the
myelin sheath [35, 36]. In the dysmyelinating disorder
metachromatic leukodystrophy (MLD) [37], arylsulfatase
A deficiency leads to accumulation of sulfatide in lyso-
somes. This causes a perturbation of the myelin structure,
which is followed by demyelination, and a delay in
remyelination. In other diseases, including multiple scle-
rosis (MS), myelin is initially formed in a correct manner,
but severe myelin loss in the absence of remyelination
results in persistent demyelination. [38]. The exact cause
for demyelination in MS is still unknown, but in contrast to
MLD a genetic origin is not likely. In MS, remyelination
failure is likely due to an altered extracellular signaling
microenvironment that among others affects the organiza-
tion of OLG membranes, which causes defects in myelin at
the molecular level [39–42].
For myelin biosynthesis to occur, progenitors cells of the
myelin producing OLGs first have to mature to myelin-
Fig. 1 Myelin structure. a Schematic model that shows the uncom-
pacted myelin sheath and the enwrapment of axons by myelin and the
localization of major myelin proteins. The major myelin protein PLP
is represented in red and MBP is represented in green. b Detailed
schematic model of myelin membrane organization and the localiza-
tion of the major myelin lipids GalC, sulfatide, cholesterol and myelin
proteins PLP and MBP within the myelin membrane. Note that
outerleaflet lipids GalC and sulfatide face each other in enwrapped
myelin. c The synthesis scheme of sulfatide and GalC. Note that GalC
is synthesized from ceramide by CGT (ceramide glucosyltransferase);
sulfatide is subsequently synthesized from GalC by CST (cerebroside
sulfotransferase)
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competent cells along a well-defined differentiation time-
line [1, 43]. In this process, OLGs synthesize myelin
specific proteins and lipids in a sequential and carefully
regulated manner. Specifically, the myelin galactolipids
GalC and sulfatide are produced prior to the expression of
PLP and MBP. Therefore, the timing of the myelination
machinery is crucial. In vivo, the generation of new myelin
sheaths per individual OLG occurs in a relatively short and
dynamic time window of approximately 5 h in zebra fish,
after which maturation of the myelin sheaths requires
another 1–2 days [44]. Also in rodents, a rather short time
window of myelin sheath generation exists, e.g. co-cultured
OLGs do not generate new myelin sheaths after 12 h [45].
Obviously, it takes much longer before the entire
(re)myelination process of an entire axon is completed
[46]. Thus, over a relatively short period of time myelin
biogenesis may require vast amounts of building blocks to
be produced within an OLG for sheath assembly. Major
issues to be resolved in this regard are the identification and
functioning of key players that orchestrate these events in a
strictly temporal and spatial manner. Throughout myelin
biogenesis and its maintenance, OLGs sort and transport
different cargos from the cell body, via primary processes
to the growing myelin sheath. In order to understand these
events it has to be taken into account that OLGs display a
polarized nature. Cell polarization is a well-known feature
of epithelial and endothelial cells, consisting of a basolat-
eral surface of a relative fluid nature and an apical surface,
which is specifically enriched in glycosphingolipid and
cholesterol, thus giving rise to a more rigid membrane
domain. OLGs contain two distinct membrane surfaces, the
plasma membrane surrounding the cell body, resembling
the basolateral membrane in terms of composition, and the
myelin membrane, which is reminiscent of an apical
membrane domain in terms of composition. The presence
of these distinct compartments might imply that polarized
sorting and transport is likely instrumental in myelin bio-
genesis [2, 47]. Indeed, previous studies from our
laboratory revealed the existence of polarized pathways in
OLGs; the myelin sheet being targeted by a basolateral-like
trafficking mechanism [2, 48], whereas transport of newly
synthesized plasma membrane proteins reach this mem-
brane via an apical-like trafficking mechanism. This shows
that OLGs display a ‘unique’ polarity, where the cell body
with the basolateral-like composition is targeted by an
apical-like trafficking mechanism whereas the more apical-
like myelin membrane is targeted by a basolateral-like
mechanism. Consistently, the t-SNAREs syntaxin 3 and 4,
which are distributed in a distinct polarized fashion in
polarized cells, localize in OLGs to the plasma membrane
and myelin membrane, respectively [2, 49]. Similarly, as
reported for its transport in epithelial cells, the apical
membrane protein marker hemagglutinin (HA) of influenza
virus is delivered to the apical-like cell body plasma
membrane in OLGs, while the VSV G protein, a basolat-
eral marker in epithelial cells, is delivered to the myelin
sheet [48]. Also, in vivo, VSV G is delivered to the inner
tongue, i.e., the leading edge of the growing myelin
membrane [29].
In more recent work evidence supports a transcytotic
transport mechanism for PLP, indicating transport of de
novo synthesized PLP from the endoplasmic reticulum to
the myelin membrane via the OLG plasma membrane [50].
From the latter membrane, newly arrived PLP appears to
be internalized via a sulfatide-mediated and clathrin-inde-
pendent but cholesterol-dependent pathway [51], and it has
been proposed that endosomal compartments may subse-
quently serve as site of storage, prior to a neuronal signal-
triggered delivery of the protein to the myelin membrane,
as inferred from data obtained in Oli-neu cells [51]. By
contrast, the peripheral membrane protein MBP, another
major myelin protein, is translated ‘on site’, following
transport of MBP mRNA containing granules towards the
myelin sheet [3, 49]. During the process of myelin wrap-
ping around the axon, both PLP protein and MBP mRNA
are continuously trafficking towards the myelin membrane
via cytoplasmic channels near the non-compacted edges of
the newly assembling myelin membrane (Fig. 1a, [52–54]).
Furthermore, stimulation of myelin synthesis leads to an
opening or closing of these cytoplasmic channels, which
further emphasizes the dynamic structure of the myelin
sheath [29].
Although considerable progress has been made in recent
years in clarifying aspects of the underlying mechanism in
myelin biogenesis in rodents, further improvement will
require detailed insight into the fundamental role of myelin
lipids and proteins in myelin assembly. We will therefore
first focus on current knowledge of the involvement of the
major myelin glycosphingolipids, i.e., the galactolipids
GalC and sulfatide.
Major myelin lipids galactosylceramide
and sulfatide and their role in the myelin
membrane
The lipid pool of myelin consists of phospholipids, plas-
mogens, cholesterol and glycosphingolipids [2, 10, 55, 56],
and does not contain unique, i.e., myelin-specific lipids.
Nevertheless, the glycosphingolipid GalC and its sulfated
derivative, sulfatide (Fig. 1c) can be considered as ‘typical’
myelin lipids because of their relative high abundance,
representing approx. 23 and 4 %, respectively, of the total
lipid pool. These lipids, often referred to as galactolipids,
are highly ordered lipids with long saturated and
monosaturated fatty acyl chains, containing 22–26 carbon
3294 H. Ozgen et al.
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atoms [57]. Cholesterol is another abundant (approx. 28 %
of the total lipid pool weight) and important structural lipid
element of the myelin membrane (Table 1; [58, 59]), not in
the least because of its ability to engage with the galac-
tolipids in the formation of specific membrane
microdomains, as will be discussed below.
Although galactolipids are important key players in
safeguarding integrity and long term maintenance of
myelin membranes, their presence does not seem to be
essential for myelin biogenesis and assembly [60–64].
Based upon in vitro studies performed in rodents, it has
been proposed that particularly GalC is important in OLG
maturation [65], whereas sulfatide plays a role in OLG
differentiation [66, 67]. However, more specific insight has
been obtained in studies in which enzymes of galactolipid
biosynthesis were downregulated, as in ceramide galacto-
syltransferase (CGT) knock-out mice, which are deficient
in GalC, and consequently in sulfatide, for which GalC
serves as a precursor (Fig. 1c, [64]). Even though myelin
ultrastructure abnormalities are observed in this model, the
biosynthesis of seemingly compacted myelin membranes
does occur. However, upon closer examination, abnormal
nodal and paranodal structures, a decrease in myelin sta-
bility over time and, importantly, disrupted axo-glia
interactions are observed [62, 64]. This pathological phe-
notype of CGT null mice can be rescued by OLG-specific
re-expression of CGT, which strongly supports the notion
that the abnormalities observed in CGT null mice were
indeed caused by GalC and/or sulfatide deficiency in OLGs
[68]. Insight into a specific role of sulfatide could be
obtained when the possibility was provided to create an
animal model in which cerebroside sulfotransferase (CST),
which is responsible for sulfatide synthesis from GalC,
could be knocked-out [63]. Although the clinical pheno-
type was less severe, CST null mouse also revealed
unstable myelin with age, disrupted paranodal compart-
ments, axonal swellings and disruption in sodium channel
clustering [10, 62]. Accordingly, these data evidently
indicate that both GalC and sulfatide play distinct roles in
OLG differentiation, myelin maintenance and overall sta-
bility and proper functioning of the myelin membrane.
Major myelin proteins PLP and MBP and their
role in the myelin membrane
Unlike its lipids, myelin expresses a unique set of proteins
including PLP, MBP, myelin oligodendrocyte glycoprotein
(MOG), myelin associated glycoprotein (MAG), 20, 30-
cyclic-nucleotide 30-phosphodiesterase (CNP) and NF155,
of which PLP and MBP are the most abundant ones ([1, 2],
Fig. 1a). Their participation in myelin biogenesis is a
carefully regulated and timed process [1]. The integral
membrane protein PLP with four membrane spanning
domains consists of two different isoforms, i.e., PLP and
DM20 [69]. PLP is expressed in late development, while
DM20 is also expressed in embryonic or early develop-
ment. Additionally, it has been shown in rats that PLP,
mainly DM20, can be expressed by a specific set of neu-
rons [70, 71]. PLP is synthesized at the endoplasmic
reticulum, traffics through the Golgi apparatus, and is then
transported in an indirect manner to the myelin membrane
via a vesicular transport pathway [35, 50, 69, 72–74]. The
protein primarily plays a role in stabilizing the intraperiod
line by bringing together the extracellular leaflets of the
myelin membrane (Fig. 1b), although PLP also participates
in many other cellular processes, such as cholesterol
transport and migration [74–77]. Nevertheless, PLP -/-
mice show no dysmyelinating phenotype, indicating that
PLP is not essential for the actual assembly of the myelin
sheath. However, PLP might be important at the ultra-
structural level once myelin has been formed, since in PLP
-/- mice the extracellular compaction of adjacent mem-
branes are abnormally condensed, which may be a sign of
reduced myelin stability [78]. Interestingly though, as yet it
cannot be excluded that another transmembrane protein
with four membrane spans, M6B, can compensate for the
lack of functional PLP in PLP knock-out animals, partic-
ularly since in case of a double knock-out of both PLP and
M6B, severe hypomyelination is observed [74]. However,
in a PLP deficient mice (PLP-neo mice), where an abnor-
mal splice product of 159 is present, a disruption of the
compacted myelin sheath was observed [79]. Also, over-
expression of PLP and any mutation or deletion in the PLP
gene causes abnormalities or severe pathological condi-
tions in the context of gain of function, i.e., mutations of
the PLP gene may cause an abnormal folding and hence
perturbed conformational features of the protein, thereby
dysregulating PLP trafficking, which results in extensive
dysmyelination and/or premature OLG death [34–36, 80–
83]. For example, duplication of PLP, as observed in PMD,
results in accumulation of cholesterol and other raft com-
ponents in an endosomal compartment. Accordingly,
proper assembly of the myelin membrane fails [35, 84],
which highlights the relevance of PLP’s presence in gov-
erning the proper assembly of cholesterol-containing
membrane microdomains [74]. In addition, PLP/DM20
mutants have been reported to accumulate in a subset of
neurons in the caudal brainstem of rats, which was
accompanied by downregulation of the NMDA and GABA
receptors [85]. Taken together, not the absence of PLP, but
the expression of properly folded PLP at physiological
levels appears to play a pivotal role in proper myelin
assembly.
Different postnatal isoforms of the peripheral membrane
protein MBP are expressed in a species-dependent manner,
Oligodendroglial membrane dynamics in relation to myelin biogenesis 3295
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i.e., four isoforms have been discerned in rats, six in mice
and four in humans. The MBP variants are produced from a
single eleven exons containing gene complex (in mice),
called Golli (‘gene in the OLG lineage’) [3, 86]. The
classical MBP isoforms are derived from alternative
splicing of a single MBP mRNA, which includes seven
most downstream exons of the Golli gene complex. Among
these isoforms, the ones containing exon-II, i.e., 17 and
21.5 kDa, shuttle between the cytoplasm and the nucleus,
whereas the others, 14 and 18.5 kDa, localize mainly in
compact myelin [3, 87, 88]. MBP is the only known
structural myelin protein absolutely required for myelin
membrane formation, presumably because of its role in
myelin membrane compaction, due to its capacity of
bringing the cytoplasmic leaflets together ([89, 90],
Fig. 1b). Furthermore (exon-II minus) MBP is a multi-
functional protein that has many different roles in
signaling, cytoskeleton (actin, tubulin) polymerization and
stability, and calcium-calmodulin binding [91–94]. In
addition, it has been proposed that (exon-II minus) MBP
serves as a molecular sieve, regulating the integration of
proteins with a small cytoplasmic domain into the myelin
membrane according to a mechanism that depends on MBP
co-clustering in a condensed network, which triggers a
phase transition in the myelin membrane and subsequently
determines the exclusion or inclusion of other proteins into
the myelin membrane [88, 95]. Because of its positive
charge, MBP, as a cytoplasmic peripheral membrane pro-
tein, can interact with anionic phospholipids [e.g.,
phosphatidylserine (PS), phosphatidylinositol (PI)] in the
inner leaflet of the myelin membrane [3]. Interestingly,
MBP dynamics is also affected by changes of the dynamics
of extracellular leaflet galactolipids [96, 97], suggesting
that ‘indirect’ interactions may occur between the galac-
tolipids, which constitute 60–70 % of the extracellular
leaflet, and MBP, facing the cytoplasmic surface of the
membrane. Moreover, by also taking into account its actin
binding properties [91, 98], MBP might be a key player in
transmitting galactolipid-derived signals.
Membrane microdomains in oligodendroglial
myelin
Role of GalC and sulfatide
Apart from their presence or absence, the biochemical
structure of galactolipids is another key factor in proper
myelin functioning. Myelin membranes are mainly com-
posed of galactolipids with very long saturated fatty acyl
chains (C22-24) [99] and these galactolipid species, toge-
ther with cholesterol and membrane proteins, are known to
assemble into important and specialized membrane
microdomains, so-called lipid rafts [100], operationally
defined as detergent-insoluble or detergent-resistant mem-
branes (for detailed reviews the reader is referred to [6, 7,
9]). Possibly, very long fatty acyl chain galactolipids are
crucial for proper myelin maintenance and stability
because they exert their function via these membrane
microdomains. In this respect, it has been well established
that membrane domain formation of the galactolipids is
dependent on the chain length, their hydroxylation and
saturation levels [101, 102]. Thus, hydroxylated or unsat-
urated lipids reveal a strongly diminished membrane
microdomain forming capacity. For instance, the acyl chain
length of sulfatide is developmentally regulated; i.e., prior
to the onset of myelin formation (day 10 in rats), stearic
acid (C18:0) is the main hydrocarbon chain present in
sulfatide, whereas between day 10 and 32, nervonoyl sul-
fatide (C24:1) is upregulated [103]. Not only chain length
but also hydroxylation of the fatty acyl chains of sulfatide
is developmentally regulated; i.e., the extent of hydroxy-
lation of sulfatides decreases with age in rats [103].
Therefore, it is also important to take into account the
nature of the fatty acid chain and its state of hydroxylation
when investigating and defining the specific role of
galactolipids. Indeed, in an animal ceramide synthase 2
(CerS2) knock-out mice model, CerS2 being responsible
for the synthesis of sphingolipids with very long (C22-24)
fatty acid chains, a marked decrease in GalC and sulfatide
levels was observed, while the phenotype showed unstable,
and non-compacted myelin, with abnormalities in the inner
lamellae [104]. Moreover, when reconstituted in a model
membrane system, myelin lipid extracts obtained from
CerS2 deficient mice, in contrast to such extracts from
control animals, do not give rise to formation of membrane
domains, [99]. Finally, with regard to hydroxylation, the
hydroxylation levels of sulfatide are remarkably increased
in MS patients. Since a decrease in hydroxylation promotes
the formation of membrane microdomains in model
membranes [102], these data suggest that such membrane
microdomains in MS patients may be relatively decreased,
which may have severe consequences for the proper
assembly and lateral organization, and hence functioning
(e.g. signaling), of the myelin membrane.
To appreciate the complexity of the myelin structure and
organization, it is crucial to understand the ability of
galactolipids to induce functional membrane microdomains
and their role in membrane compaction. Such knowledge
will require further insight as to how extracellular leaflet
lipids transmit signals from and/or to the intracellular
environment. For example, it has been proposed that
galactolipids, given their relatively long fatty acyl chains,
might interfere with the (lipid) organization in the inner
leaflet as a result of acyl chain interdigitation, thereby
‘transmitting’ the signal. Consistent with this proposal,
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123
studies performed in model membranes indeed revealed
that ceramide with C24:0 chains forms interdigitated gel
phases [105]. Alternatively, it is also possible that galac-
tolipid-mediated signal transmission proceeds via integral
myelin membrane-specific proteins such as PLP, MAG or
MOG. Consistent with such a possibility are observations
that clustering of GalC in OLGs, occurring upon interac-
tion of the cells with GalC-sulfatide liposomes, also causes
clustering of the membrane spanning proteins PLP and
MOG [106]. However, as yet, there is no direct evidence of
a direct interaction between galactolipids and these integral
membrane proteins, although such interactions might well
be revealed by applying appropriate biophysical techniques
or model membranes, as will be discussed in detail below
(‘‘Biophysical tools to investigate oligodendroglial-myelin
membranes’’).
Myelin proteins and their membrane microdomain
association
Membrane microdomains are composed of lipids and
specific membrane proteins [9, 100, 107]. Hence, the par-
titioning behavior of integral or peripheral membrane
proteins might have a pivotal effect on cellular activities
dominated by lipid rafts, acting for example as signaling
platforms. Several major and minor myelin membrane
proteins are known to reside in membrane microdomains
[6]. Operationally, these domains are often defined by their
different detergent solubility behavior. For example, in
myelin sheet-directed transport, following de novo
biosynthesis, the major myelin protein PLP initially dis-
plays Triton-X100 (TX-100) insolubility, and acquires
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesul-
fonate (CHAPS) insolubility at later steps in the transport
pathway [2, 50, 106]. Remarkably, as a peripheral mem-
brane protein, MBP also displays different detergent
solubility behavior, as observed at different stages of OLG
differentiation [108] and especially phosphorylated forms
of MBP become CHAPS-insoluble at the myelin mem-
brane [109]. Proteins such as NF155, MAL, and MOG
display TX-100 insolubility or acquire TX-100 solubility
by crosslinking (MOG); MAG, however, is Lubrol WX
insoluble [6, 110], while NF155 and MAL in addition
display Lubrol WX and CHAPS insolubility, respectively
[30, 111]. The different detergent solubility properties
might reflect the dynamic partitioning of the proteins in
different membrane microdomains in OLGs and myelin.
It is still poorly understood whether myelin lipids rep-
resent the driving force in the lateral organization of
myelin proteins or vice versa. In this regard, in differenti-
ating OLGs, myelin galactolipids are expressed prior to
myelin proteins [43]. Consistently, also our recent findings,
derived from work in which conventional raft isolation
procedures with detergent extraction were combined with
optical biophysical techniques, revealed that sulfatide
determines PLP’s partitioning into CHAPS-resistant
membrane microdomains, whereas for MBP, the presence
of GalC rather than sulfatide was pertinent for the protein’s
partitioning in detergent-insoluble microdomains [50, 97].
In further support, several knock-out animal studies also
suggest the importance of the membrane lipid composition
in organizing the lateral distribution of myelin proteins into
distinct membrane microdomains within the myelin sheath
[73, 112]. Thus, in the CGT knock-out animal model the
absence of galactolipids altered PLP’s association with
CHAPS-insoluble membrane microdomans, i.e., under
knock-out conditions PLP is largely CHAPS-soluble [73].
Similarly, inhibition of sphingolipid synthesis in primary
OLGs disrupts the CHAPS-insolubility of PLP and MBP
[73, 112]. However, in these studies it was also reported
that in shiverer mice, where MBP is absent, a large fraction
of PLP appears CHAPS-soluble, which could suggest that
next to the presence of membrane galactolipids, the protein
composition of the myelin membrane is also important for
the lateral segregation of proteins [112]. However, in
shiverer mice the galactolipid content decreases as well
[90], implying that the membrane microdomain association
of PLP might also be a consequence of an altered galac-
tolipid content, which will require additional experimental
work.
Biophysical tools to investigate oligodendroglial-
myelin membranes
Model systems to study myelin lipid and proteins
Cell systems and model membranes
A need for further detailed mechanistic studies into the
fundamental role of GalC and sulfatide in myelin biogen-
esis and maintenance is apparent from observations as
reported above in knock-out animal models. For this pur-
pose, one of the widely used models are rat or mouse OLG
primary cell cultures [88, 95, 113]. These OLG primary
cell cultures provide the possibility to study myelin mem-
branes in vitro, since these cells, grown in monoculture,
follow the same developmental pattern as in vivo. In fact,
all the myelin components are expressed in a coordinated
fashion and transported to the different subdomains in the
myelin sheet, which are to a certain extent also compacted
[88]. Moreover, the thinly flattened myelin-like sheets
formed in monoculture, make them highly suitable for
studies of intracellular trafficking, as compared to OLGs
in vivo, where the myelin membrane is wrapped spirally
around the myelinated axons. Hence, by taking into
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account the sequential expression of the galactolipids,
primary cell cultures are an appropriate tool to tackle lipid-
specific questions. Nevertheless, in these monocultures it is
not possible to study the physiological complexity of the
multi-layered myelin membranes, as in the case in the
presence of the axons. For this purpose, the use of different
culture systems in which OLGs and neurons are co-cul-
tured can be applied to study myelin membranes while
enwrapping axons [45, 114, 115]. However, with these
in vitro models it is not possible to apply a reductionist
approach, in which one can selectively express myelin
lipids and proteins other than along its physiological
expression timeline.
A convenient model for such reductionist studies
appears to be OLG progenitor cell lines such as OLN-93
cells, which express neither GalC nor sulfatide [116].
However, in this rat-derived cell line, GalC or GalC and
sulfatide can be readily and selectively expressed by cel-
lular transfection with appropriate constructs of CGT,
giving rise to the exclusive expression of GalC, and CGT/
CST, which results in production of both GalC and sul-
fatide [97, 113]. However, an obvious limitation of this cell
system is that the effect of sulfatide cannot be investigated
as such, given that GalC serves as its precursor. Although
addition of extracellular sulfatide to parental OLN-93 cells
is an option, it is questionable whether exogenously
inserted sulfatide will reside in the correct membrane
domain. Alternatively, Oli-neu cells, an immature OLG
cell line from mice, are also widely used in OLG-myelin
research. However, these cells have the ‘disadvantage’ that
they are not suitable for myelin lipid-dependent research,
since they do express GalC and sulfatide, which is pro-
moted upon differentiation by cAMP [117].
An attractive option to study specific myelin lipid-re-
lated questions is the application of simple membrane
systems such as large unilamellar vesicles (LUVs), which
may provide detailed insight into lipid–protein interactions
between myelin lipids and protein [14], as will be discussed
in the next section. An obvious choice would also be the
use of model membranes such as giant unilamellar vesicles
(GUVs). These model membranes are composed of lipids
in which liquid ordered (Lo) and disordered (Ld) phases
can coexist in a lipid composition dependent manner [118].
Thus, biological membranes have a special order and this
order can be altered upon internal or external stimuli. For
example, it is believed that the formation of so called ‘lipid
rafts’ changes the membrane order and makes it tighter. In
the case of model membranes like GUVs, it is also possible
to create an order where some lipids can be tightly packed
with different lipid compositions rather than having a
homogenous lipid distribution. The liquid ordered phase
displays a tight packing of lipids, similar as occurs in ‘lipid
rafts’, whereas adjacent, less tightly packed lipids, the so
called liquid disordered phase, displays a more fluidic
environment (for further readings please see [11, 13, 119,
120]). In contrast to the relatively small LUVs, GUVs
display diameters that may vary between 10 and 100 lm
which makes them most convenient for visual inspection
by optical microscopy. GUVs can be prepared from syn-
thetic or natural lipids, allowing a large variation in fatty
acyl chain length, hydroxylation levels, nature of the lipid
head groups, and overall lipid composition [121, 122]. For
example, GUVs reconstituted with GalC, sulfatide and
glucosylceramide at similar ratios as present in myelin,
revealed that depending on its concentration, glucosylce-
ramide containing GUVs are fairly unstable (our
unpublished observations), which might explain why in the
absence of GalC and sulfatide, the upregulation of gluco-
sylceramide synthesis cannot compensate for these
galactolipids [123]. GUVs can also be prepared from nat-
ural lipid extracts [124, 125] or isolated native cell
membranes [126]. In this manner, the lateral segregation of
lipids extracted from different animal models, displaying
different degrees in myelin perturbation, have been inves-
tigated. Thus, in GUVs prepared from myelin extracts
obtained from MBP-deficient shiverer mice and CerS2-
deficient mice, no membrane microdomain formation could
be detected [99]. Nevertheless, domain formation in GUVs
can be readily visualized using a fluorescent marker, which
specifically attaches to the lipid of interest. For example,
domain formation in GUVs, reconstituted with neuronal
lipid extracts, was visualized with fluorescently-tagged
cholera toxin, which specifically binds to ganglioside GM1,
and with monoclonal antibody R24, which specifically
binds to ganglioside GD3, to study the heterogeneity of the
lipid rafts [127]. It is also possible to visualize phase sep-
aration behavior by using fluorescent lipid probes such as
DIC, DIO, or DiD, which prefer partitioning in membrane
domains, depending on their fluidity [128]. However,
variability in results when applying these probes in
detecting the liquid ordered or disordered phases have been
reported, implying that care should be taken when inter-
preting the data. For example, DiIC18 showed preferential
partitioning into the gel phases in GUVs, prepared from
POPC (diacylglycerol and phospholipid)/sphingomyelin,
whereas the probe partitioned into the fluid phase in GUVs
prepared from POPC/DPPC (phospholipid) [128]. More-
over, although fluorescently labeled lipid analogues can be
directly applied in the preparation of GUVs, it has also
been reported that factors like the chemical structure of the
fluorescent probe, the positioning of the fluorophore in the
lipid analogue, the lipid composition of the bilayer, the
chemical structure of the fatty acyl chain of the lipid
analogue, and some thermodynamic properties such as the
temperature, might change dramatically the domain for-
mation behavior as such (reviewed in [129]).
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The specific preference of myelin proteins for micro-
domains composed of distinct lipids can also be visualized
in reconstituted model membrane systems (GUVs) by
optical microscopy. Particularly as a myelin membrane
model, it is relevant of being able to reconstitute GUVs
selectively with either sulfatide or GalC. An important step
of such procedures is of course the proper integration of the
protein of interest in the reconstituted membrane. There are
in fact several options to incorporate proteins into these
model membranes [12, 130–132] and the preparation pro-
cedure depends on the nature of the protein.
Mimicking myelin membranes
To study the function of myelin membrane proteins or
lipids can be troublesome with simple cell line systems or
model membranes, because myelin membranes are the only
membrane platform of which the extracellular leaflets of
the same membrane are opposing each other, thereby
giving rise to a multilamellar complex structure (Fig. 1b).
Therefore, by using in vitro model systems consisting of a
combined system of cells and opposing model membranes,
the major dense line or intraperiod line can thus be mim-
icked, allowing a better understanding of the function of
the major myelin proteins MBP and PLP, and myelin
galactolipids.
Upon myelination, the sugar moieties of the myelin
galactolipids, which exclusively localize at the extracellu-
lar leaflet in myelin, are facing each other. This fact
prompted Boggs et al. to propose that myelin membranes
might have a ‘glycosynapse’, where carbohydrate groups
from opposing membranes are interacting [96, 106, 133].
Indeed, liposomes and nanoparticles, consisting of either
GalC or both GalC and sulfatide, when incubated with
primary OLGs, mimicking the intraperiod line as described
above, are capable of inducing (1) a redistribution/clus-
tering of GalC at the extracellular leaflet, (2) a
reorganization of MBP at the cytoplasmic side of the
membrane, and (3) a disruption of the actin cytoskeleton
and tubulin network in OLGs [133, 134]. These fascinating
observations highlight a potential role of galactolipids in
creating signaling platforms, thereby regulating myelin
compaction by perturbing MBP-membrane interaction and
affecting cytoskeletal dynamics. In addition, galactolipids
might act as their own receptors, receiving and/or trans-
mitting signals via the glycosynapse in a density dependent
manner [133]. Indeed, in this context, it has been recently
demonstrated that the density and confluency of the coat of
negatively charged oligosaccharides (i.e., the glycocalyx,
in particular provided by the galactolipids in OLGs), may
cause repulsion of the opposing membranes, and that this
density-dependent electrostatic repulsion between oppos-
ing membranes is effectively downregulated upon
differentiation of the OLG, i.e., conditions at which the
myelin membrane is generated [135]. Furthermore, in the
same study, the formation of the IPL was also mimicked by
addition of liposomes or intraperiod line membranes from
PLP knock-out mice. However, not unexpectedly, a proper
interaction between the liposomes and the membranes of
mature OLGs [135] was perturbed, supporting the role of
PLP in the stabilization of intraperiod line and adhesion of
extracellular leaflets of myelin to each other. Taken toge-
ther, a partial loss of the glycocalyx might create an
appropriate molecular and spatial environment for
engagement of the galactolipids. This holds in particular
for GalC as this lipid localizes in compact parts of the
internodes, in (transient) interactions between opposing
membranes in a PLP-dependent manner, thereby promot-
ing myelin development and compaction.
Recently, it has been proposed that MBP is a major
molecular factor inmaintaining the high lipid to protein ratio
in myelin by a mechanism in which it acts as a molecular
sieve and diffusion barrier [88]. Next to the primary cell
system, a biomimetic system was applied to study the
physical barrier properties of MBP in which the apposition
of the cytoplasmic part of the myelin membrane (major
dense line) was mimicked by using supported bilayers
(SPLSs), consisting of cytoplasmic leaflet lipids of myelin,
and GUVs consisting of phosphatidylserine (PS) and phos-
phatidylcholine (PC). In this system, the distribution of a
positively charged membrane-anchored GFP was monitored
in the presence or absence of MBP. In the absence of MBP,
membrane-anchored GFP, sandwiched between SPLs and
GUVs, revealed a homogenous distribution whereas addi-
tion of MBP to this system caused a reallocation of GUVs to
distinct areas on the SPLs, from which GFP was partially
excluded. When MBP was sandwiched between SPLs and
GUVs prior to addition of membrane-anchored GFP, a total
exclusion of GFP occurred from the spread areas to which
GUVs were attached. These data support the notion that
MBP can also exert its physical barrier function in vitro
systems, a conclusion that is most conveniently reached by
employing a biomimetic system that allows freedom in the
addition of relevant compounds. The sequential inclusion of
MBP in this model system thus supports the protein’s ability




In general, the molecular organization of the lipids within
the membrane creates a special environment for the correct
distribution of the protein and presumably, lipids and
proteins may be considered as an ‘interactive team’, which
determines the general structure and the assembly of the
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membranes. In the previous sections, we summarized
findings indicative of the existence of lipid/protein cross-
talk in OLGs and myelin membranes, largely inferred from
biochemical and cell biological approaches. This cross-
talk, as reflected by microdomains, or ‘‘rafts’’, is also
proposed to be very important for specific cellular func-
tions because of their highly dynamic properties, i.e., they
can be transiently formed upon external stimulation, which
then might stimulate internal signaling, as occurs via the
‘glycosynapse’. However, when and how ‘rafts’ affect the
dynamic properties of a membrane is still poorly under-
stood. Therefore, a better understanding of these dynamics
within the OLG cell body plasma membrane and myelin
might shed light on crucial mechanisms, playing a role in
the proper organization of the myelination machinery.
Within this context, the application of advanced method-
ologies such as a combined approach of cell biology and
biophysics might be most rewarding in improving our
understanding (recent achievements are summarized in
Table 2).
Measuring membrane order (fluidity)
Membrane ordering/fluidity is determined by the presence
or absence of membrane microdomains, and regulates
membrane dynamics and rigidity and thereby the




[182] FCS Diffusion coefficient of MOG-eGFP and Bodipy FL-C5 sphingomyelin
[112] C-Laurdan In co-culture systems (neuron-derived signals):
Increased membrane order in primary OLGs by neuron-derived soluble factors
Increased membrane condensation in the presence of MBP
FRAP Formation of highly dynamic GalC clusters in OLGs
STED Increased number of large GalC clusters in the presence of neurons
FRET Self-interaction of GalC within the large clusters
[136] FRET Decrease in Rho activity in Oli-neu cells in the presence of neuronal-conditioned medium
C-Laurdan Increased membrane condensation in the presence of conditioned neuronal medium or RhoGTPase inactivation
[183] RICS, FRAP Diffusion coefficient of MOG-eGFP in OLN-93 cells
[164] FRET Interaction of 14-kDa MBP with PIP2 (sensed by CFP-PH-PLCd1) in Oli-neu cells
[184] RICS, FRAP Diffusion coefficient of DiI-C18 in primary OLGs
[99] C-Laurdan Higher lipid order in GUVs prepared from myelin compared to Oli-neu cells
Higher lipid order in GUVs prepared from wild type animal compared to shiverer mousea or CerS2-deficient
mouseb
Higher lipid order in primary OLGs compared to FB1c-treated OLGs
FCS Slower diffusion of DiD in GUVs prepared from wild type animal compared shiverera mouse or CerS2 deficient
mouse
FRAP Slower diffusion of Cell MaskOranged in control OLGs compared to FB1c-treated OLGs
[88] FRAP Detection of highly mobile MAG in OLGs isolated from shiverer mouse compared to control to show the
diffusion barrier function of 14-kDa MBP
Higher mobility of truncated Tmem10 (without cytosolic domain) compared to full length Tmem10
[87] FRAP Dynamic role of 21.5-kDa MBP-RFP in OLN-93 cells proliferation
[95] FRAP Decreased 14-kDa MBP diffusion due to its oligomerization
FRET Self association of 14-kDa MBP
[97] s-FCS Decreased mobility of PLP-eGFP in the presence of sulfatide (rather than GalC) on poly-L-lysine and laminin-2
in OLN-93 cells
Increased mobility of PLP-eGFP even in the presence of sulfatide on fibronectin in OLN-93 cells
z-scan FCS,
z-scan RICS
Increased mobility of 18.5-MBP-eGFP in the presence of only GalC in OLN-93 cells
[166] FRET Presence of one or more intermediate conformational states of 18.5-kDa MBP
a MBP-deficient mouse
b Mouse model unable to synthesize long acid fatty acyl chain lipids
c Inhibitor of sphingolipid synthesis
d Membrane dye
3300 H. Ozgen et al.
123
functioning of the membrane. Evidence is accumulating
that myelin membrane order/fluidity is largely dependent
on two major factors; firstly, the molecular composition of
the myelin membrane; i.e., the abundance of long chain,
microdomain forming galactolipids, and the presence of the
peripheral membrane protein MBP. For instance, GUVs
reconstituted with membrane extracts from CerS2-deficient
mice devoid of long fatty acyl galactolipids, or from
shiverer mice, devoid of MBP, revealed a decrease of
membrane order compared to that of wild type animals
[99]. In a similar way, the membrane fluidity is relatively
increased in primary OLGs (1) derived from shiverer mice
or (2) following fumonisin B1-mediated inhibition of
sphingolipid synthesis. Secondly, myelin membrane fluid-
ity is under tight control of neuron-derived soluble signals.
The incubation of primary OLGs and Oli-neu cells with
conditioned neuronal medium displayed increased mem-
brane condensation [112, 136].
To determine the state of membrane ordering, fluores-
cent probes which specifically partition into liquid ordered
or disordered phases are often used to investigate such
domain formation in model membranes. However, the
choice of probe in terms of obtaining unambiguous results
can be rather challenging. For that reason, the application
of different types of environmentally sensitive membrane
dyes, such as di-4-ANEPPDHQ, Laurdan, PY3304,
PY3174, and PY3184, is recommended [128, 137]. Par-
ticularly the use of Laurdan has greatly contributed to
clarifying important biophysical issues in myelin mem-
brane dynamics [138, 139]. This fluorescent probe is
sensitive to membrane phase transitions and membrane
fluidity. Thus the emission spectrum of membrane inserted
Laurdan undergoes a blue shift from 500 to 430 nm, when
the membrane domain in which the probe partitions
undergoes a phase change from a liquid-disordered to liq-
uid-ordered state. By monitoring, therefore, the
fluorescence signal from two channels, it is possible to
compose a generalized polarization (GP) image which
provides the possibility to calculate the membrane order
[128, 140]. The application of C-Laurdan, which has a
greater membrane environment-dependent sensitivity and a
diminished susceptibility towards photobleaching, further
boosted its versatile use [139]. A particular advantage of
this dye is that it homogenously distributes in the lateral
plane of the membrane, while differences in membrane
order are simply inferred from changes in its emission
spectrum. Another advantage is that, (C-)Laurdan is suit-
able for use in both model and cell membranes.
Taken together, further applications of (C-)Laurdan can
rule out other factors, i.e., soluble signals such as pro-
inflammatory cytokines present in MS lesions or different
extracellular matrix proteins, affecting the OLG-myelin
membrane order and therefore dynamics. Moreover, the
application of (C-)Laurdan to model membranes reconsti-
tuted from MS patient material or myelin lipids with
modifications such as fatty acyl chain length, and
hydroxylation (see above), can clarify the extent to which
diseases such as MS can affect membrane order and how
such changes may relate to physiological consequences.
Notably, another approach, next to membrane order sen-
sitive dyes, is Coherent anti-stokes Raman scattering
(CARS) imaging. This particular technique does not
require any labeling, since it determines the membrane
order by relying on the molecular vibrations of the sample
(for detailed information please read [141]). This technique
can be even applied to live tissues. Also in the myelin field,
CARS microscopy serves as an important tool to compare
membrane order in healthy and diseased (e.g., EAE) ani-
mals [142, 143].
Measuring membrane dynamics
Even though membrane probes, such as (C-)Laurdan, or
techniques such as CARS may provide insight into overall
OLG-myelin membrane dynamics, such tools cannot
extract dynamic information, originating from a specific
lipid or protein, i.e., its lateral mobility. Therefore, to
obtain more detailed information on the molecular
dynamics, more advanced optical microscopic techniques
in conjunction with sophisticated analyses are required,
which can be applied to both living cells and model
membranes. One such approach relies on FRAP, which is
widely used to investigate molecular dynamics in biologi-
cal systems, including myelin (recent findings are
summarized in Table 2). FRAP allows quantification of
dynamic information such as determination of the envi-
ronment-dependent diffusion coefficient and the mobile
fraction of the molecules of interest by applying a high
laser power to bleach a region of interest (ROI), and
recording the rate of fluorescence recovery (Fig. 2a).
However, strictly speaking, FRAP cannot be considered as
a non-invasive technique because of the usage of a high
laser power to bleach fluorescently-labeled molecules in
the ROI. In addition, FRAP cannot provide single molecule
specificity, as is possible for other biophysical techniques
such as fluorescent correlation spectroscopy (FCS). FCS is
a powerful non-invasive biophysical technique, allowing
determination of dynamical properties by applying very
low laser light on a single point in the cell or at the cell’s
surface, and recording the fluorescence fluctuations created
by the diffusion of the fluorescently labeled molecules in
and out the area of interest, which allows the determination
of diffusion coefficients, and thereby the lateral mobility.
However, given the complexity of the plasma and myelin
membrane of OLGs, the application of more advanced
approaches of FCS, in terms of acquired information and
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effectivity, are recommended (for a review see [144],
Fig. 2b). Powerful options include scanning FCS, which
provides the possibility to measure diffusion of the mole-
cules simultaneously at different locations [145], and z-
scan FCS, which provides the possibility to measure dif-
fusion in different z planes, such as near the upper or
bottom plasma membrane of plated cells [21].
Even though FCS has a high temporal resolution, it
lacks spatial resolution, which may hamper determination
of the membrane dynamics in cell types with complex
morphology, like OLGs. Accordingly, image correlation
techniques have been developed to deduce dynamic
information from live cell systems; however, these tech-
niques were not ideal because of their poor temporal
resolution. A more recent technique, named raster image
correlation spectroscopy (RICS) combined the temporal
and spatial resolution in a confocal setup to make it more
convenient for live cell systems. RICS can be applied with
a conventional scanning confocal setup and allows for
elimination of the immobile fractions from the obtained
image and provides possibilities to select more precise
spots within the ROI. However, restrictions are also readily
apparent, in particular to apply RICS to very heteroge-
neously distributed proteins such as PLP, which localizes
to a variety of transport vesicles, the cell body plasma
membrane, the myelin membrane and, presumably, other
intracellular (endosomal) membranes. In these kind of
situations, it is more beneficial to apply biophysical tech-
niques, such as circular scan FCS, where disruptions
caused by vesicular structures can be eliminated (Fig. 2b,
for further details please read [97]).
By application of techniques as described in the previ-
ous paragraph, evidence has been obtained that distinct
myelin lipids act as key players in regulating the lateral
mobility behavior of myelin proteins, and thereby OLG-
myelin membrane dynamics. By using an FCS approach,
Gielen et al. showed a membrane microdomain dependent
change in the lateral mobility of BODIPY-labeled sphin-
gomyelin in parental OLN-93 plasma membranes upon
cholesterol depletion, a procedure that destroys membrane
micodromain integrity. Additionally, we recently applied
circular scan FCS to determine the dynamics of PLP-eGFP,
and z-scan FCS and RICS to determine the dynamics of
MBP-eGFP in relation to the myelin lipids GalC and sul-
fatide. The mobility of PLP decreased in the presence of
sulfatide, which presumably reflects PLP-eGFP’s associa-
tion with CHAPS-insoluble membrane microdomains
under those conditions, as determined by classical bio-
chemical means (detergent extraction). Additionally, the
same study revealed that MBP dynamics was mainly
governed by the presence of GalC, consistent with a
potential signal transmission capacity between exoplasmic
expressed GalC and MBP, which localizes at the
cytoplasmic surface ([97], Table 2). Similarly, the lipid
mobility measured by FCS in GUVs, reconstituted from
myelin membranes of CerS2-deficient mice, devoid of long
fatty acyl chain galactolipids and where membrane
microdomain formation is not observed, was significantly
faster than the rates determined in reconstituted membranes
from healthy animals [99]. Hence, these findings provide
new insight as to how the membrane microdomain forming
nature of myelin (galacto)lipids might regulate the lateral
mobility of myelin enriched lipids and specific proteins. In
line with these findings, a combination of biochemical and
biophysical studies suggested that the presence of the
extracellular matrix protein fibronectin, a pathological
condition which inhibits myelin membrane formation and
impairs remyelination in MS lesions, might alter the
membrane microdomain organization in OLG membranes
by shifting sulfatide out of such domains [113]. As a
consequence, the membrane microdomain association and
the lateral mobility of PLP is likely affected [97]. These
studies thus further suggest that the perturbation of the
equilibrium of membrane microdomains in OLGs under
diseased conditions may result in alterations in lateral
mobility of myelin specific proteins. However, further
investigations are needed to improve our understanding
concerning the link between membrane microdomain
association of a protein/lipid and its lateral mobility, which
will be further discussed below.
Measuring membrane dynamics in relation to membrane
microdomains
The mobility of microdomain associated fluorescently
labeled lipid molecules has been extensively studied in a
variety of model membranes by biophysical techniques
such as FCS. In this manner it has been shown, for
example, that in GUVs, the raft marker ganglioside GM1
diffuses relatively slowly, whereas the non-raft marker
dialkylcarbocyanine dye diffuses considerably faster. This
kind of studies support the notion that the dynamic
behavior of a lipid is closely related to its microdomain
association, i.e., microdomain associated lipids diffuse
slower in the membrane. However, unlike in model
membrane systems, where domain formation can be easily
visualized due to their non-specific clustering, visualization
of microdomains in native biological membranes is chal-
lenging given their size and life time. For example, in early
work performed by FRAP analysis it was concluded that
the lateral mobility of raft associated proteins is not nec-
essarily slower than that of non-raft proteins [146]. On the
other hand, in an elegant study relying on a sophisticated
laser trap procedure, Pralle et al., demonstrated that when
glycosylphosphatidylinositol (GPI) -anchored and trans-
membrane proteins are raft-associated, their diffusion
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becomes independent of the type of membrane anchor and
is significantly reduced compared with that of non-raft
transmembrane proteins [147].
Different approaches have been proposed in order to
obtain a more direct clue on the dynamics of membrane
proteins or lipids in relation to their membrane micro-
domain association. Marguet et al., proposed for the first
time the spot variation FCS approach [22], based on the
idea of the diffusion law, which was reviewed in detail in
[8]. Briefly, in this method, the focal volume size where
molecules pass through as a result of their diffusion
properties is changed and the transient time that molecules
spend in each focal volume is measured. Subsequently, the
plotted transient time versus focal volume (focal spot area)
gives three different diffusion patterns; free diffusion and
hindered diffusion by either the cytoskeleton and/or a
membrane microdomain (Fig. 2b). In that respect, spot
variation FCS can be very informative for myelin research
because it provides direct information about whether the
lipids and proteins diffuse in a membrane microdomain or
in a cytoskeleton-dependent manner. As an alternative to
spot variation FCS, z-scan FCS makes it possible to
Fig. 2 Biophysical applications. a. FRAP (fluorescence recovery
after photobleaching) application in a living cell (for more details see
the text). The laser beam depicted in red reflects 100 % laser power.
The corresponding graph shows the fluorescence recovery after
bleaching. b FCS (fluorescence correlation spectroscopy) applications
in a living cell (for more details see the text). The laser beam is
depicted in orange and the diffusing molecules in red. Fluorescently
labeled molecules diffusing through the detection volume give rise to
fluorescence fluctuations in time (i) which can be converted to the
autocorrelation curve to determine the half decay. By fitting the
autocorrelation curve with mathematical models, particle number,
diffusion time/coefficient can be calculated (ii). c Schematic repre-
sentation of RICS (raster image correlation spectroscopy). Temporal
information can be extracted from raster scan images as these images
are recorded pixel by pixel (for details see [26, 27]). A representative
autocorrelation curve, the weighted residuals and corresponding
2D1C fit model is shown from a z-scan RICS measurement for
18.5 kDa MBP-eGFP. d (i) Schematic representation of FRET
(fluorescence resonance energy transfer) and FCSS (fluorescence
cross correlation spectroscopy). The red fluorophore is excited by
laser light, which transfers its energy of the excited photon in a
radiation-less manner to the green fluorophore which is thus excited
and as a result emits light. For this so called principle of energy
transfer, the distance between two fluorophores should be 20 nm or
less. (ii) The red and green fluorophore diffuse together through the
confocal volume (see b) which reveals cross correlation, depicted by
the black cross-correlation curve in the corresponding graph
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determine the different diffusion types extracted by spot
variation FCS in a commercial confocal setup [21]. In the
z-scan, the diffusion time is plotted versus the ratio
between the particle number at each z plane and the initial
particle number. The first comparative study by z-scan FCS
of the diffusion behavior of DiD in supported phospholipid
bilayers (SPB) and OLN-93 cells, suggested that DiD dif-
fuses freely in SPB while in OLN-93 cells the probe
displays hindered diffusion due to the probe’s localization
in rafts [21]. Therefore, an in-depth investigation about the
type of diffusion behavior of myelin proteins or lipids,
especially in primary OLGs, can provide further insight
into the various diffusion types, such as hindered diffusion
as a result of their association with microdomains and/or
the cytoskeleton, which may differ at healthy versus
pathological conditions.
Lipid–protein and protein–protein interactions
in oligodendroglial-myelin membranes
As evidenced by both biophysical and biochemical studies,
the influence of myelin lipids on myelin proteins, for
example in terms of trafficking and functioning, is of
obvious relevance. However, the above mentioned studies
do not provide direct information about the interactions
between myelin lipids and proteins. To study such inter-
actions, previous in vitro studies performed with artificial
membranes such as LUVs with purified myelin proteins
(especially MBP) provided detailed insight into myelin
protein- inner leaflet lipid interaction as well as self-in-
teraction of MBP [91, 148–153]. For instance, these studies
revealed that MBP/inner leaflet lipid ratios in myelin
membranes are quite crucial for MBPs ability to bind to
negatively charged cytoplasmic leaflet lipids such as PS
and PI; i.e., in the case of an MBP/lipid ratio, lower than
that in compact myelin, MBP’s ability to induce aggrega-
tion of lipid bilayers decreases dramatically. Accordingly,
since the concentration of the acidic phospholipid PS is
dramatically increased in OLGs of MS patients, the MBP/
lipid ratio is relatively decreased, which may thus lead to
an impairment of MBP’s ability to mediate the adhesion of
apposed cytoplasmic leaflets [154]. Additionally, studies
performed with LUVs suggested that post-translational
modifications of MBP such as deimination, which is dra-
matically increased in MS patients, might also change
MBPs ability to adhere to the membrane [3, 155–157].
Since post-translational modifications of a protein may
alter its structure and thereby its function dramatically, the
effect of altered post-translational modifications of MBP
can be studied at the structural by solid-state NMR [158].
Besides, the self-association of MBP near cytosolic leaflet
lipids was shown to be non-random, but regular to some
degree, by double electron–electron resonance (DEER)
spectroscopy and solid-state NMR studies [148, 159]. In
fact, these studies can be elaborated with more sensitive
NMR technique called dynamic nuclear polarization
(DNP) which is able to perform structural studies in bio-
logically complex environments [160]. Moreover, a
potential interaction of MBP with PIP(2), a minor com-
ponent of the cytoplasmic leaflet of myelin, was first
suggested with LUVs studies [161] and this data was fur-
ther supported by showing the co-distribution MBP with
PIP(2) sequestering proteins in primary rat OLGs by
putative raft extraction [162].
Clearly, these kinds of approaches only provide detailed
information at the model membrane level. At the cellular
level, these interactions can be much more complex,
especially when taking into account the presence of the
extracellular leaflet lipids. In that sense, optical biophysical
techniques such as FRET or fluorescence cross-correlation
spectroscopy (Fig. 2d), where the measurements are done
in live intact cells, can be very effective tools to investigate
these interactions. The FRET technique relies on the
principle of energy transfer between two chromophores,
which depends on the distance between the molecules; i.e.,
if the distance between two molecules decreases then the
efficiency of energy transfer increases (for details see
[163], Fig. 2d). For example, by means of FRET, evidence
was obtained showing that MBP and PIP2 interact at the
plasma membrane of Oli-neu cells, providing the possi-
bility to investigate the interactions of molecules within
special compartments of the cells [164]. However, in some
cases FRET cannot detect these interactions due to the
distance limit. In those cases fluorescence cross-correlation
spectroscopy might serve as a more informative tool
because fluorescence cross-correlation spectroscopy deter-
mines whether two molecules are co-diffusing within the
same confocal volume, independent of the distance [165,
23]. In that regard, it will be of interest to explore co-
movement of major myelin proteins with (fluorescently
labeled) lipids under different conditions, for example with
or without the establishment of the ‘glycosynapse’, as
discussed above. Alternatively, FRET can also be used to
investigate the ‘self-interaction’ of the proteins. For
instance, the self-association of MBP, and hence its
oligomerization, has been revealed by a FRET study and
the self-association of MBP on LUVs was also studied by a
complementary biophysical technique, DEER [95, 148].
Moreover, a different approach for investigating the ‘self-
interactions’ of proteins may also rely on specific tech-
niques such as number and brightness analysis (N&B) or
photon counting histogram (PCH) [16], which also allow
determination of the degree of oligomerization. Such
applications can provide further opportunities to investi-
gate the potential oligomerization of PLP, which has been
proposed to be regulated by sulfatide [50]. Also the
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conformational changes of PLP, can be investigated by
FRET technique which has been applied to investigate
conformational transitions of MBP [166].
Especially by considering the polarized nature of OLGs,
these techniques, in conjunction with the unique opportu-
nity of visualization by optical microscopy, can provide
opportunities to specifically investigate ‘local’ lipid–pro-
tein and protein–protein interactions as well as protein
oligomerization in the different regions (cell body and
plasma membrane vs myelin sheath) in myelinating OLGs.
Conclusion and outlook
Developing OLGs are exposed to many changes in their
internal and external environment. Until the myelin sheath
is synthesized and all the myelin-related components reach
their proper destination, OLG-myelin membranes contin-
uously undergo lateral reorganization. Hence, OLGs should
display a very dynamic structure in order to regulate this
series of events. Our knowledge about myelin biogenesis
and OLG-myelin membrane dynamics is gradually
improving. However, there are still numerous questions to
be raised. For example, why does myelin display a unique
galactolipid composition, and more specifically, why are
membrane microdomain forming lipids highly enriched in
myelin? How is this molecular organization formed and
organized in space and time in the multi-lamellar compact
myelin sheath? Do microdomain forming lipids have dif-
ferent role in compact and non-compact myelin? To what
extent do membrane microdomains composed of galac-
tolipids determine myelin membrane dynamics? In order to
address and/or provide answers to these questions, neces-
sary for revealing and clarifying vital internal mechanisms
related to pathological demyelinating conditions, a detailed
understanding of membrane dynamics of (human-derived)
OLGs in the presence of axons and in myelin is needed.
Most studies have been performed with rat or mouse
OLGs, and validation and further studies in a human setting
is an unmet need. Since it is rather difficult to culture
primary human OLGs from post mortem tissue, the appli-
cation of induced pluripotent stem cells may be the way to
go, particularly since the composition of human myelin
differs from that of rodent myelin [167]. Also, the lipid and
protein composition of myelin, the latter also at the post-
translational level, differ in MS lesions as compared to
healthy brain [168, 169]. To visualize the distribution of
posttranslational modified protein, imaging mass spec-
trometry (IMS), a rapidly emerging technique that allows
for spatial profiling of post translational modified proteins
in biological tissues and single cells, may be applied [170].
In fact, with this technique the in situ distribution of
palmitoylated PLP and DM20 in rat brain was shown
[171]. However this will not resolve the question whether
the change in composition is a cause or consequence in
MS. The composition of newly formed myelin after
remyelination per se as compared to myelin formed upon
development may differ, rather than that the disease alters
the composition. On the other hand, given the altered
myelin composition in normal appearing white matter
[172], disease-specific extrinsic, but also OPC-related
intrinsic factors, may contribute to the altered lipid and
posttranslational signature of MS myelin. Also here
patient-derived induced pluripotent stem cells are an
interesting option to pursue on.
Here, we have summarized the role ofmyelin proteins and
lipids in myelin biogenesis and introduced different models
to study myelin biogenesis-related questions, and have
illustrated how biophysical techniques can be exploited for
this purpose (Table 2). For instance, optical microscopic
applications, next to conventional biochemical techniques,
already served as very informative tools to investigate the
sophisticated biology of OLGs and myelin membranes. In
addition, optical biophysical techniques prove to represent
powerful, versatile tools in the analyses of protein and lipid
dynamics in living OLGs in a non-invasive way.
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